BACKGROUND: The JUPITER trial has recently demonstrated an outstanding reduction of cardiovascular events by 20 mg rosuvastatin/day in subjects with high CRP wh...

作者：国际循环网 发布于：2010-12-06

BACKGROUND: HDL-cholesterol concentrations are inversely associated with occurrence of cardiovascular events. We addressed， using the JUPITER trial cohort， wh...

作者：国际循环网 发布于：2010-12-06

Abstract Objective: This study assessed the long-term cost effectiveness of rosuvastatin therapy compared with placebo in reducing the incidence of major cardio...

作者：国际循环网 发布于：2010-12-06

Abstract Objective: This study assessed the long-term cost effectiveness of rosuvastatin therapy compared with placebo in reducing the incidence of major cardio...

作者：国际循环网 发布于：2010-12-06

BACKGROUND: Recent primary prevention guidelines issued in Canada endorse the use of statin therapy among individuals at "intermediate risk" who have elevated l...

作者：国际循环网 发布于：2010-12-06

Aims On the basis of the JUPITER trial， European health authorities recently approved the use of rosuvastatin to reduce first major cardiovascular events among...

作者：国际循环网 发布于：2010-12-06

BACKGROUND: A potentially adverse vascular response to overlapping drug eluting stents (DES) has been suggested in current research

作者：国际循环网 发布于：2010-12-06

Background: Optical coherence tomography (OCT) permits a highly accurate NIH assessment at each strut level within a cross-section. The aim of this study is to ...

作者：国际循环网 发布于：2010-12-06

OBJECTIVES: This study sought to assess the relationship between 1-year mortality and baseline patient risk in the HORIZONS-AMI (Harmonizing Outcomes with Revas...

作者：国际循环网 发布于：2010-12-06

OBJECTIVES: We sought to identify patients with ST-segment elevation myocardial infarction most likely to benefit from drug-eluting stents (DES)， and to evalua...

作者：国际循环网 发布于：2010-12-06